Derivatives of clavulanic acid, a process for their preparation and their use
AssigneeBeecham Group Limited
InventorsBrian P. Clarke, John B. Harbridge, Irene Stirling
Life of this patent
Estimating the term…
Loading patent…
AssigneeBeecham Group Limited
InventorsBrian P. Clarke, John B. Harbridge, Irene Stirling
Estimating the term…
The compounds of the formula (II): ##STR1## or pharmaceutically acceptable salts or esters thereof wherein A is a hydrogen atom or an esterifying radical; X is an alkyl group of 1-12 carbon atoms optionally substituted by a hydroxy, amino, acylamino of C.sub.1-6 alkoxy group, which substituents are not on the carbon atom adjacent to the nitrogen atom; or a C.sub.5-7 cycloalkyl group; or a phenylalkyl group wherein the carbon atom content of the alkyl part is 1-6 and the phenyl part is optionally substituted with a fluorine, bromine, chlorine, C.sub.1-6 alkyl, or C.sub.1-6 alkoxy; with the proviso that when X represents an optionally substituted phenylalkyl group and A represents C.sub.1-3 alkyl, then the --CO.sub.2 A group is attached to the alkyl part of the phenylalkyl group; have been found to be .beta.-lactamase inhibitors and antibacterial agents. Their preparation and use is described.
A pharmaceutical composition having enhanced antibacterial activity comprising a synergistically effective amount of a compound of formula (II):
A pharmaceutical composition having enhanced antibacterial activity comprising a synergistically effective amount of 9-N-(2'-carboxyethyl) aminodeoxyclavulanic acid as synergist and an antibacterially effective amount of amoxycillin as the active antibiotic.
Dependencies are inferred from the claim text.